Correlation von Willebrand factor levels cardiovascular hemodynamics BACKGROUND Valvular heart disease decreased platelet circulating time thrombotic tendency possibility events changes von Willebrand factor vWF multimeric glycoprotein endothelial cells platelets platelet adhesion vascular subendothelium METHODS RESULTS vWF antigen vWF Ag concentration patients undergoing cardiac catheterization evaluation mitral aortic stenosis nonvalvular heart disease Mean vWF Ag concentration patients mitral stenosis versus units/dl elevation significant elevation pulmonary vascular resistance PVR patients mitral stenosis versus vWF Ag levels entire group patients regardless presence type valvular disease PVR pulmonary artery pressure cardiac output Changes PVR pulmonary artery pressure cardiac output circulating levels fibrinogen beta-thromboglobulin activated platelets endothelial cell product tissue plasminogen activator CONCLUSIONS association high vWF Ag levels PVR cardiac output patients mitral stenosis induced increase endothelial release vWF thrombotic tendency patients 